nodes	percent_of_prediction	percent_of_DWPC	metapath
Hydrocodone—CYP2D6—Tamoxifen—pancreatic cancer	0.0762	0.203	CbGbCtD
Hydrocodone—CYP2D6—Erlotinib—pancreatic cancer	0.0648	0.173	CbGbCtD
Hydrocodone—CYP3A4—Tamoxifen—pancreatic cancer	0.0484	0.129	CbGbCtD
Hydrocodone—CYP3A4—Erlotinib—pancreatic cancer	0.0412	0.11	CbGbCtD
Hydrocodone—CYP3A4—Irinotecan—pancreatic cancer	0.0372	0.0993	CbGbCtD
Hydrocodone—CYP2D6—Doxorubicin—pancreatic cancer	0.032	0.0853	CbGbCtD
Hydrocodone—CYP3A4—Docetaxel—pancreatic cancer	0.0273	0.0728	CbGbCtD
Hydrocodone—CYP3A4—Sunitinib—pancreatic cancer	0.0271	0.0725	CbGbCtD
Hydrocodone—CYP3A4—Doxorubicin—pancreatic cancer	0.0203	0.0543	CbGbCtD
Hydrocodone—Insomnia—Sunitinib—pancreatic cancer	0.00107	0.00272	CcSEcCtD
Hydrocodone—Paraesthesia—Sunitinib—pancreatic cancer	0.00106	0.0027	CcSEcCtD
Hydrocodone—Dyspnoea—Sunitinib—pancreatic cancer	0.00105	0.00268	CcSEcCtD
Hydrocodone—Cough—Irinotecan—pancreatic cancer	0.00104	0.00265	CcSEcCtD
Hydrocodone—Gastrointestinal disorder—Sunitinib—pancreatic cancer	0.00102	0.0026	CcSEcCtD
Hydrocodone—Fatigue—Sunitinib—pancreatic cancer	0.00102	0.00259	CcSEcCtD
Hydrocodone—Hypersensitivity—Tamoxifen—pancreatic cancer	0.00102	0.00259	CcSEcCtD
Hydrocodone—Cough—Gemcitabine—pancreatic cancer	0.00101	0.00258	CcSEcCtD
Hydrocodone—Constipation—Sunitinib—pancreatic cancer	0.00101	0.00257	CcSEcCtD
Hydrocodone—Asthenia—Tamoxifen—pancreatic cancer	0.00099	0.00252	CcSEcCtD
Hydrocodone—Convulsion—Fluorouracil—pancreatic cancer	0.00099	0.00252	CcSEcCtD
Hydrocodone—Arthralgia—Gemcitabine—pancreatic cancer	0.00099	0.00252	CcSEcCtD
Hydrocodone—Myalgia—Gemcitabine—pancreatic cancer	0.00099	0.00252	CcSEcCtD
Hydrocodone—Hot flush—Epirubicin—pancreatic cancer	0.000988	0.00251	CcSEcCtD
Hydrocodone—Agranulocytosis—Docetaxel—pancreatic cancer	0.000985	0.00251	CcSEcCtD
Hydrocodone—Unspecified disorder of skin and subcutaneous tissue—Gemcitabine—pancreatic cancer	0.000983	0.0025	CcSEcCtD
Hydrocodone—Asthenia—Erlotinib—pancreatic cancer	0.00098	0.00249	CcSEcCtD
Hydrocodone—Menopausal symptoms—Epirubicin—pancreatic cancer	0.000979	0.00249	CcSEcCtD
Hydrocodone—Pruritus—Tamoxifen—pancreatic cancer	0.000977	0.00248	CcSEcCtD
Hydrocodone—Myalgia—Fluorouracil—pancreatic cancer	0.000973	0.00248	CcSEcCtD
Hydrocodone—Gastrointestinal pain—Sunitinib—pancreatic cancer	0.000967	0.00246	CcSEcCtD
Hydrocodone—Pruritus—Erlotinib—pancreatic cancer	0.000966	0.00246	CcSEcCtD
Hydrocodone—Nervous system disorder—Irinotecan—pancreatic cancer	0.000955	0.00243	CcSEcCtD
Hydrocodone—Thrombocytopenia—Irinotecan—pancreatic cancer	0.000954	0.00243	CcSEcCtD
Hydrocodone—Lethargy—Epirubicin—pancreatic cancer	0.000943	0.0024	CcSEcCtD
Hydrocodone—Hyperhidrosis—Irinotecan—pancreatic cancer	0.000941	0.0024	CcSEcCtD
Hydrocodone—Body temperature increased—Sunitinib—pancreatic cancer	0.000935	0.00238	CcSEcCtD
Hydrocodone—Abdominal pain—Sunitinib—pancreatic cancer	0.000935	0.00238	CcSEcCtD
Hydrocodone—Oedema peripheral—Docetaxel—pancreatic cancer	0.000933	0.00237	CcSEcCtD
Hydrocodone—Connective tissue disorder—Docetaxel—pancreatic cancer	0.000931	0.00237	CcSEcCtD
Hydrocodone—Nervous system disorder—Gemcitabine—pancreatic cancer	0.00093	0.00237	CcSEcCtD
Hydrocodone—Thrombocytopenia—Gemcitabine—pancreatic cancer	0.000929	0.00236	CcSEcCtD
Hydrocodone—Osteoarthritis—Epirubicin—pancreatic cancer	0.000924	0.00235	CcSEcCtD
Hydrocodone—Pain in extremity—Epirubicin—pancreatic cancer	0.000924	0.00235	CcSEcCtD
Hydrocodone—Skin disorder—Gemcitabine—pancreatic cancer	0.000921	0.00234	CcSEcCtD
Hydrocodone—Hyperhidrosis—Gemcitabine—pancreatic cancer	0.000917	0.00233	CcSEcCtD
Hydrocodone—Nervous system disorder—Fluorouracil—pancreatic cancer	0.000915	0.00233	CcSEcCtD
Hydrocodone—Hot flush—Doxorubicin—pancreatic cancer	0.000914	0.00232	CcSEcCtD
Hydrocodone—Thrombocytopenia—Fluorouracil—pancreatic cancer	0.000913	0.00232	CcSEcCtD
Hydrocodone—Dizziness—Tamoxifen—pancreatic cancer	0.000913	0.00232	CcSEcCtD
Hydrocodone—Hypotension—Irinotecan—pancreatic cancer	0.00091	0.00232	CcSEcCtD
Hydrocodone—Affect lability—Epirubicin—pancreatic cancer	0.000909	0.00231	CcSEcCtD
Hydrocodone—Migraine—Epirubicin—pancreatic cancer	0.000909	0.00231	CcSEcCtD
Hydrocodone—Menopausal symptoms—Doxorubicin—pancreatic cancer	0.000906	0.0023	CcSEcCtD
Hydrocodone—Dizziness—Erlotinib—pancreatic cancer	0.000903	0.0023	CcSEcCtD
Hydrocodone—Hypotension—Gemcitabine—pancreatic cancer	0.000886	0.00226	CcSEcCtD
Hydrocodone—Insomnia—Irinotecan—pancreatic cancer	0.000881	0.00224	CcSEcCtD
Hydrocodone—Vomiting—Tamoxifen—pancreatic cancer	0.000878	0.00223	CcSEcCtD
Hydrocodone—Mood swings—Epirubicin—pancreatic cancer	0.000875	0.00223	CcSEcCtD
Hydrocodone—Paraesthesia—Irinotecan—pancreatic cancer	0.000874	0.00222	CcSEcCtD
Hydrocodone—Lethargy—Doxorubicin—pancreatic cancer	0.000872	0.00222	CcSEcCtD
Hydrocodone—Hypotension—Fluorouracil—pancreatic cancer	0.000872	0.00222	CcSEcCtD
Hydrocodone—Hypersensitivity—Sunitinib—pancreatic cancer	0.000871	0.00222	CcSEcCtD
Hydrocodone—Rash—Tamoxifen—pancreatic cancer	0.00087	0.00221	CcSEcCtD
Hydrocodone—Dermatitis—Tamoxifen—pancreatic cancer	0.00087	0.00221	CcSEcCtD
Hydrocodone—Vomiting—Erlotinib—pancreatic cancer	0.000868	0.00221	CcSEcCtD
Hydrocodone—Dyspnoea—Irinotecan—pancreatic cancer	0.000868	0.00221	CcSEcCtD
Hydrocodone—Somnolence—Irinotecan—pancreatic cancer	0.000866	0.0022	CcSEcCtD
Hydrocodone—Headache—Tamoxifen—pancreatic cancer	0.000865	0.0022	CcSEcCtD
Hydrocodone—Musculoskeletal discomfort—Gemcitabine—pancreatic cancer	0.000864	0.0022	CcSEcCtD
Hydrocodone—Rash—Erlotinib—pancreatic cancer	0.000861	0.00219	CcSEcCtD
Hydrocodone—Dermatitis—Erlotinib—pancreatic cancer	0.00086	0.00219	CcSEcCtD
Hydrocodone—Angiopathy—Docetaxel—pancreatic cancer	0.00086	0.00219	CcSEcCtD
Hydrocodone—Dehydration—Epirubicin—pancreatic cancer	0.000859	0.00219	CcSEcCtD
Hydrocodone—Insomnia—Gemcitabine—pancreatic cancer	0.000858	0.00218	CcSEcCtD
Hydrocodone—Headache—Erlotinib—pancreatic cancer	0.000856	0.00218	CcSEcCtD
Hydrocodone—Pain in extremity—Doxorubicin—pancreatic cancer	0.000855	0.00217	CcSEcCtD
Hydrocodone—Osteoarthritis—Doxorubicin—pancreatic cancer	0.000855	0.00217	CcSEcCtD
Hydrocodone—Mediastinal disorder—Docetaxel—pancreatic cancer	0.000854	0.00217	CcSEcCtD
Hydrocodone—Paraesthesia—Gemcitabine—pancreatic cancer	0.000852	0.00217	CcSEcCtD
Hydrocodone—Musculoskeletal discomfort—Fluorouracil—pancreatic cancer	0.00085	0.00216	CcSEcCtD
Hydrocodone—Asthenia—Sunitinib—pancreatic cancer	0.000848	0.00216	CcSEcCtD
Hydrocodone—Dyspnoea—Gemcitabine—pancreatic cancer	0.000846	0.00215	CcSEcCtD
Hydrocodone—Insomnia—Fluorouracil—pancreatic cancer	0.000844	0.00215	CcSEcCtD
Hydrocodone—Somnolence—Gemcitabine—pancreatic cancer	0.000843	0.00215	CcSEcCtD
Hydrocodone—Affect lability—Doxorubicin—pancreatic cancer	0.000841	0.00214	CcSEcCtD
Hydrocodone—Migraine—Doxorubicin—pancreatic cancer	0.000841	0.00214	CcSEcCtD
Hydrocodone—Hypokalaemia—Epirubicin—pancreatic cancer	0.000841	0.00214	CcSEcCtD
Hydrocodone—Gastrointestinal disorder—Irinotecan—pancreatic cancer	0.000841	0.00214	CcSEcCtD
Hydrocodone—Fatigue—Irinotecan—pancreatic cancer	0.00084	0.00214	CcSEcCtD
Hydrocodone—Paraesthesia—Fluorouracil—pancreatic cancer	0.000838	0.00213	CcSEcCtD
Hydrocodone—Pruritus—Sunitinib—pancreatic cancer	0.000836	0.00213	CcSEcCtD
Hydrocodone—Constipation—Irinotecan—pancreatic cancer	0.000833	0.00212	CcSEcCtD
Hydrocodone—Dyspnoea—Fluorouracil—pancreatic cancer	0.000832	0.00212	CcSEcCtD
Hydrocodone—Mental disorder—Docetaxel—pancreatic cancer	0.00083	0.00211	CcSEcCtD
Hydrocodone—Somnolence—Fluorouracil—pancreatic cancer	0.000829	0.00211	CcSEcCtD
Hydrocodone—Malnutrition—Docetaxel—pancreatic cancer	0.000825	0.0021	CcSEcCtD
Hydrocodone—Nausea—Tamoxifen—pancreatic cancer	0.00082	0.00209	CcSEcCtD
Hydrocodone—Gastrointestinal disorder—Gemcitabine—pancreatic cancer	0.000819	0.00208	CcSEcCtD
Hydrocodone—Fatigue—Gemcitabine—pancreatic cancer	0.000818	0.00208	CcSEcCtD
Hydrocodone—Constipation—Gemcitabine—pancreatic cancer	0.000811	0.00206	CcSEcCtD
Hydrocodone—Nausea—Erlotinib—pancreatic cancer	0.000811	0.00206	CcSEcCtD
Hydrocodone—Mood swings—Doxorubicin—pancreatic cancer	0.00081	0.00206	CcSEcCtD
Hydrocodone—Gastrointestinal disorder—Fluorouracil—pancreatic cancer	0.000805	0.00205	CcSEcCtD
Hydrocodone—Back pain—Docetaxel—pancreatic cancer	0.000798	0.00203	CcSEcCtD
Hydrocodone—Gastrointestinal pain—Irinotecan—pancreatic cancer	0.000796	0.00203	CcSEcCtD
Hydrocodone—Dehydration—Doxorubicin—pancreatic cancer	0.000795	0.00202	CcSEcCtD
Hydrocodone—Muscle spasms—Docetaxel—pancreatic cancer	0.000793	0.00202	CcSEcCtD
Hydrocodone—Dizziness—Sunitinib—pancreatic cancer	0.000782	0.00199	CcSEcCtD
Hydrocodone—Hypokalaemia—Doxorubicin—pancreatic cancer	0.000778	0.00198	CcSEcCtD
Hydrocodone—Abdominal pain—Irinotecan—pancreatic cancer	0.00077	0.00196	CcSEcCtD
Hydrocodone—Body temperature increased—Irinotecan—pancreatic cancer	0.00077	0.00196	CcSEcCtD
Hydrocodone—Vomiting—Sunitinib—pancreatic cancer	0.000752	0.00191	CcSEcCtD
Hydrocodone—Body temperature increased—Gemcitabine—pancreatic cancer	0.00075	0.00191	CcSEcCtD
Hydrocodone—Rash—Sunitinib—pancreatic cancer	0.000745	0.0019	CcSEcCtD
Hydrocodone—Dermatitis—Sunitinib—pancreatic cancer	0.000745	0.00189	CcSEcCtD
Hydrocodone—Upper respiratory tract infection—Epirubicin—pancreatic cancer	0.000742	0.00189	CcSEcCtD
Hydrocodone—Headache—Sunitinib—pancreatic cancer	0.000741	0.00188	CcSEcCtD
Hydrocodone—Body temperature increased—Fluorouracil—pancreatic cancer	0.000737	0.00188	CcSEcCtD
Hydrocodone—Cough—Docetaxel—pancreatic cancer	0.00072	0.00183	CcSEcCtD
Hydrocodone—Hypersensitivity—Irinotecan—pancreatic cancer	0.000718	0.00183	CcSEcCtD
Hydrocodone—Convulsion—Docetaxel—pancreatic cancer	0.000715	0.00182	CcSEcCtD
Hydrocodone—Drowsiness—Epirubicin—pancreatic cancer	0.000712	0.00181	CcSEcCtD
Hydrocodone—Arthralgia—Docetaxel—pancreatic cancer	0.000702	0.00179	CcSEcCtD
Hydrocodone—Myalgia—Docetaxel—pancreatic cancer	0.000702	0.00179	CcSEcCtD
Hydrocodone—Nausea—Sunitinib—pancreatic cancer	0.000702	0.00179	CcSEcCtD
Hydrocodone—Asthenia—Irinotecan—pancreatic cancer	0.000699	0.00178	CcSEcCtD
Hydrocodone—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—pancreatic cancer	0.000697	0.00177	CcSEcCtD
Hydrocodone—Urinary tract infection—Epirubicin—pancreatic cancer	0.000692	0.00176	CcSEcCtD
Hydrocodone—Hypersensitivity—Fluorouracil—pancreatic cancer	0.000687	0.00175	CcSEcCtD
Hydrocodone—Dry mouth—Docetaxel—pancreatic cancer	0.000687	0.00175	CcSEcCtD
Hydrocodone—Upper respiratory tract infection—Doxorubicin—pancreatic cancer	0.000687	0.00175	CcSEcCtD
Hydrocodone—Asthenia—Gemcitabine—pancreatic cancer	0.000681	0.00173	CcSEcCtD
Hydrocodone—Pruritus—Gemcitabine—pancreatic cancer	0.000671	0.00171	CcSEcCtD
Hydrocodone—Agranulocytosis—Epirubicin—pancreatic cancer	0.000664	0.00169	CcSEcCtD
Hydrocodone—Nervous system disorder—Docetaxel—pancreatic cancer	0.00066	0.00168	CcSEcCtD
Hydrocodone—Pruritus—Fluorouracil—pancreatic cancer	0.00066	0.00168	CcSEcCtD
Hydrocodone—Thrombocytopenia—Docetaxel—pancreatic cancer	0.000659	0.00168	CcSEcCtD
Hydrocodone—Drowsiness—Doxorubicin—pancreatic cancer	0.000659	0.00168	CcSEcCtD
Hydrocodone—Skin disorder—Docetaxel—pancreatic cancer	0.000654	0.00166	CcSEcCtD
Hydrocodone—Dizziness—Irinotecan—pancreatic cancer	0.000644	0.00164	CcSEcCtD
Hydrocodone—Urinary tract infection—Doxorubicin—pancreatic cancer	0.00064	0.00163	CcSEcCtD
Hydrocodone—Oedema peripheral—Epirubicin—pancreatic cancer	0.00063	0.0016	CcSEcCtD
Hydrocodone—Hypotension—Docetaxel—pancreatic cancer	0.000629	0.0016	CcSEcCtD
Hydrocodone—Connective tissue disorder—Epirubicin—pancreatic cancer	0.000628	0.0016	CcSEcCtD
Hydrocodone—Vomiting—Irinotecan—pancreatic cancer	0.000619	0.00158	CcSEcCtD
Hydrocodone—Dizziness—Fluorouracil—pancreatic cancer	0.000617	0.00157	CcSEcCtD
Hydrocodone—Agranulocytosis—Doxorubicin—pancreatic cancer	0.000615	0.00156	CcSEcCtD
Hydrocodone—Rash—Irinotecan—pancreatic cancer	0.000614	0.00156	CcSEcCtD
Hydrocodone—Dermatitis—Irinotecan—pancreatic cancer	0.000613	0.00156	CcSEcCtD
Hydrocodone—Musculoskeletal discomfort—Docetaxel—pancreatic cancer	0.000613	0.00156	CcSEcCtD
Hydrocodone—Headache—Irinotecan—pancreatic cancer	0.00061	0.00155	CcSEcCtD
Hydrocodone—Insomnia—Docetaxel—pancreatic cancer	0.000609	0.00155	CcSEcCtD
Hydrocodone—Paraesthesia—Docetaxel—pancreatic cancer	0.000605	0.00154	CcSEcCtD
Hydrocodone—Vomiting—Gemcitabine—pancreatic cancer	0.000603	0.00153	CcSEcCtD
Hydrocodone—Dyspnoea—Docetaxel—pancreatic cancer	0.0006	0.00153	CcSEcCtD
Hydrocodone—Somnolence—Docetaxel—pancreatic cancer	0.000598	0.00152	CcSEcCtD
Hydrocodone—Rash—Gemcitabine—pancreatic cancer	0.000598	0.00152	CcSEcCtD
Hydrocodone—Dermatitis—Gemcitabine—pancreatic cancer	0.000598	0.00152	CcSEcCtD
Hydrocodone—Headache—Gemcitabine—pancreatic cancer	0.000594	0.00151	CcSEcCtD
Hydrocodone—Vomiting—Fluorouracil—pancreatic cancer	0.000593	0.00151	CcSEcCtD
Hydrocodone—Rash—Fluorouracil—pancreatic cancer	0.000588	0.0015	CcSEcCtD
Hydrocodone—Dermatitis—Fluorouracil—pancreatic cancer	0.000588	0.00149	CcSEcCtD
Hydrocodone—Headache—Fluorouracil—pancreatic cancer	0.000584	0.00149	CcSEcCtD
Hydrocodone—Oedema peripheral—Doxorubicin—pancreatic cancer	0.000583	0.00148	CcSEcCtD
Hydrocodone—Gastrointestinal disorder—Docetaxel—pancreatic cancer	0.000581	0.00148	CcSEcCtD
Hydrocodone—Connective tissue disorder—Doxorubicin—pancreatic cancer	0.000581	0.00148	CcSEcCtD
Hydrocodone—Fatigue—Docetaxel—pancreatic cancer	0.00058	0.00148	CcSEcCtD
Hydrocodone—Angiopathy—Epirubicin—pancreatic cancer	0.00058	0.00148	CcSEcCtD
Hydrocodone—Nausea—Irinotecan—pancreatic cancer	0.000578	0.00147	CcSEcCtD
Hydrocodone—Mediastinal disorder—Epirubicin—pancreatic cancer	0.000576	0.00147	CcSEcCtD
Hydrocodone—Constipation—Docetaxel—pancreatic cancer	0.000576	0.00146	CcSEcCtD
Hydrocodone—Nausea—Gemcitabine—pancreatic cancer	0.000563	0.00143	CcSEcCtD
Hydrocodone—Mental disorder—Epirubicin—pancreatic cancer	0.00056	0.00142	CcSEcCtD
Hydrocodone—Malnutrition—Epirubicin—pancreatic cancer	0.000556	0.00142	CcSEcCtD
Hydrocodone—Nausea—Fluorouracil—pancreatic cancer	0.000554	0.00141	CcSEcCtD
Hydrocodone—Gastrointestinal pain—Docetaxel—pancreatic cancer	0.00055	0.0014	CcSEcCtD
Hydrocodone—Back pain—Epirubicin—pancreatic cancer	0.000538	0.00137	CcSEcCtD
Hydrocodone—Angiopathy—Doxorubicin—pancreatic cancer	0.000537	0.00137	CcSEcCtD
Hydrocodone—Muscle spasms—Epirubicin—pancreatic cancer	0.000535	0.00136	CcSEcCtD
Hydrocodone—Mediastinal disorder—Doxorubicin—pancreatic cancer	0.000533	0.00136	CcSEcCtD
Hydrocodone—Abdominal pain—Docetaxel—pancreatic cancer	0.000532	0.00135	CcSEcCtD
Hydrocodone—Body temperature increased—Docetaxel—pancreatic cancer	0.000532	0.00135	CcSEcCtD
Hydrocodone—Mental disorder—Doxorubicin—pancreatic cancer	0.000518	0.00132	CcSEcCtD
Hydrocodone—Malnutrition—Doxorubicin—pancreatic cancer	0.000515	0.00131	CcSEcCtD
Hydrocodone—Back pain—Doxorubicin—pancreatic cancer	0.000498	0.00127	CcSEcCtD
Hydrocodone—Hypersensitivity—Docetaxel—pancreatic cancer	0.000496	0.00126	CcSEcCtD
Hydrocodone—Muscle spasms—Doxorubicin—pancreatic cancer	0.000495	0.00126	CcSEcCtD
Hydrocodone—Cough—Epirubicin—pancreatic cancer	0.000486	0.00124	CcSEcCtD
Hydrocodone—Asthenia—Docetaxel—pancreatic cancer	0.000483	0.00123	CcSEcCtD
Hydrocodone—Convulsion—Epirubicin—pancreatic cancer	0.000482	0.00123	CcSEcCtD
Hydrocodone—Pruritus—Docetaxel—pancreatic cancer	0.000476	0.00121	CcSEcCtD
Hydrocodone—Arthralgia—Epirubicin—pancreatic cancer	0.000474	0.00121	CcSEcCtD
Hydrocodone—Myalgia—Epirubicin—pancreatic cancer	0.000474	0.00121	CcSEcCtD
Hydrocodone—Anxiety—Epirubicin—pancreatic cancer	0.000472	0.0012	CcSEcCtD
Hydrocodone—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—pancreatic cancer	0.00047	0.0012	CcSEcCtD
Hydrocodone—Dry mouth—Epirubicin—pancreatic cancer	0.000463	0.00118	CcSEcCtD
Hydrocodone—Cough—Doxorubicin—pancreatic cancer	0.000449	0.00114	CcSEcCtD
Hydrocodone—Convulsion—Doxorubicin—pancreatic cancer	0.000446	0.00113	CcSEcCtD
Hydrocodone—Nervous system disorder—Epirubicin—pancreatic cancer	0.000445	0.00113	CcSEcCtD
Hydrocodone—Dizziness—Docetaxel—pancreatic cancer	0.000445	0.00113	CcSEcCtD
Hydrocodone—Thrombocytopenia—Epirubicin—pancreatic cancer	0.000445	0.00113	CcSEcCtD
Hydrocodone—Skin disorder—Epirubicin—pancreatic cancer	0.000441	0.00112	CcSEcCtD
Hydrocodone—Hyperhidrosis—Epirubicin—pancreatic cancer	0.000439	0.00112	CcSEcCtD
Hydrocodone—Arthralgia—Doxorubicin—pancreatic cancer	0.000438	0.00112	CcSEcCtD
Hydrocodone—Myalgia—Doxorubicin—pancreatic cancer	0.000438	0.00112	CcSEcCtD
Hydrocodone—Anxiety—Doxorubicin—pancreatic cancer	0.000437	0.00111	CcSEcCtD
Hydrocodone—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—pancreatic cancer	0.000435	0.00111	CcSEcCtD
Hydrocodone—Dry mouth—Doxorubicin—pancreatic cancer	0.000429	0.00109	CcSEcCtD
Hydrocodone—Vomiting—Docetaxel—pancreatic cancer	0.000428	0.00109	CcSEcCtD
Hydrocodone—Rash—Docetaxel—pancreatic cancer	0.000424	0.00108	CcSEcCtD
Hydrocodone—Hypotension—Epirubicin—pancreatic cancer	0.000424	0.00108	CcSEcCtD
Hydrocodone—Dermatitis—Docetaxel—pancreatic cancer	0.000424	0.00108	CcSEcCtD
Hydrocodone—Headache—Docetaxel—pancreatic cancer	0.000422	0.00107	CcSEcCtD
Hydrocodone—Musculoskeletal discomfort—Epirubicin—pancreatic cancer	0.000414	0.00105	CcSEcCtD
Hydrocodone—Nervous system disorder—Doxorubicin—pancreatic cancer	0.000412	0.00105	CcSEcCtD
Hydrocodone—Thrombocytopenia—Doxorubicin—pancreatic cancer	0.000411	0.00105	CcSEcCtD
Hydrocodone—Insomnia—Epirubicin—pancreatic cancer	0.000411	0.00104	CcSEcCtD
Hydrocodone—Skin disorder—Doxorubicin—pancreatic cancer	0.000408	0.00104	CcSEcCtD
Hydrocodone—Paraesthesia—Epirubicin—pancreatic cancer	0.000408	0.00104	CcSEcCtD
Hydrocodone—Hyperhidrosis—Doxorubicin—pancreatic cancer	0.000406	0.00103	CcSEcCtD
Hydrocodone—Dyspnoea—Epirubicin—pancreatic cancer	0.000405	0.00103	CcSEcCtD
Hydrocodone—Somnolence—Epirubicin—pancreatic cancer	0.000404	0.00103	CcSEcCtD
Hydrocodone—Nausea—Docetaxel—pancreatic cancer	0.0004	0.00102	CcSEcCtD
Hydrocodone—Hypotension—Doxorubicin—pancreatic cancer	0.000393	0.000999	CcSEcCtD
Hydrocodone—Gastrointestinal disorder—Epirubicin—pancreatic cancer	0.000392	0.000997	CcSEcCtD
Hydrocodone—Fatigue—Epirubicin—pancreatic cancer	0.000391	0.000996	CcSEcCtD
Hydrocodone—Constipation—Epirubicin—pancreatic cancer	0.000388	0.000988	CcSEcCtD
Hydrocodone—Musculoskeletal discomfort—Doxorubicin—pancreatic cancer	0.000383	0.000974	CcSEcCtD
Hydrocodone—Insomnia—Doxorubicin—pancreatic cancer	0.00038	0.000967	CcSEcCtD
Hydrocodone—Paraesthesia—Doxorubicin—pancreatic cancer	0.000377	0.00096	CcSEcCtD
Hydrocodone—Dyspnoea—Doxorubicin—pancreatic cancer	0.000375	0.000953	CcSEcCtD
Hydrocodone—Somnolence—Doxorubicin—pancreatic cancer	0.000374	0.00095	CcSEcCtD
Hydrocodone—Gastrointestinal pain—Epirubicin—pancreatic cancer	0.000371	0.000945	CcSEcCtD
Hydrocodone—Gastrointestinal disorder—Doxorubicin—pancreatic cancer	0.000363	0.000923	CcSEcCtD
Hydrocodone—Fatigue—Doxorubicin—pancreatic cancer	0.000362	0.000922	CcSEcCtD
Hydrocodone—Constipation—Doxorubicin—pancreatic cancer	0.000359	0.000914	CcSEcCtD
Hydrocodone—Abdominal pain—Epirubicin—pancreatic cancer	0.000359	0.000913	CcSEcCtD
Hydrocodone—Body temperature increased—Epirubicin—pancreatic cancer	0.000359	0.000913	CcSEcCtD
Hydrocodone—Gastrointestinal pain—Doxorubicin—pancreatic cancer	0.000344	0.000874	CcSEcCtD
Hydrocodone—Hypersensitivity—Epirubicin—pancreatic cancer	0.000335	0.000851	CcSEcCtD
Hydrocodone—Abdominal pain—Doxorubicin—pancreatic cancer	0.000332	0.000845	CcSEcCtD
Hydrocodone—Body temperature increased—Doxorubicin—pancreatic cancer	0.000332	0.000845	CcSEcCtD
Hydrocodone—Asthenia—Epirubicin—pancreatic cancer	0.000326	0.000829	CcSEcCtD
Hydrocodone—Pruritus—Epirubicin—pancreatic cancer	0.000321	0.000817	CcSEcCtD
Hydrocodone—Hypersensitivity—Doxorubicin—pancreatic cancer	0.00031	0.000788	CcSEcCtD
Hydrocodone—Asthenia—Doxorubicin—pancreatic cancer	0.000301	0.000767	CcSEcCtD
Hydrocodone—Dizziness—Epirubicin—pancreatic cancer	0.0003	0.000764	CcSEcCtD
Hydrocodone—Pruritus—Doxorubicin—pancreatic cancer	0.000297	0.000756	CcSEcCtD
Hydrocodone—Vomiting—Epirubicin—pancreatic cancer	0.000289	0.000735	CcSEcCtD
Hydrocodone—Rash—Epirubicin—pancreatic cancer	0.000286	0.000728	CcSEcCtD
Hydrocodone—Dermatitis—Epirubicin—pancreatic cancer	0.000286	0.000728	CcSEcCtD
Hydrocodone—Headache—Epirubicin—pancreatic cancer	0.000284	0.000724	CcSEcCtD
Hydrocodone—Dizziness—Doxorubicin—pancreatic cancer	0.000278	0.000707	CcSEcCtD
Hydrocodone—Nausea—Epirubicin—pancreatic cancer	0.00027	0.000686	CcSEcCtD
Hydrocodone—Vomiting—Doxorubicin—pancreatic cancer	0.000267	0.00068	CcSEcCtD
Hydrocodone—Rash—Doxorubicin—pancreatic cancer	0.000265	0.000674	CcSEcCtD
Hydrocodone—Dermatitis—Doxorubicin—pancreatic cancer	0.000265	0.000673	CcSEcCtD
Hydrocodone—Headache—Doxorubicin—pancreatic cancer	0.000263	0.00067	CcSEcCtD
Hydrocodone—Nausea—Doxorubicin—pancreatic cancer	0.00025	0.000635	CcSEcCtD
Hydrocodone—OPRK1—Signaling by GPCR—AGTR1—pancreatic cancer	0.000151	0.000651	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—CCKBR—pancreatic cancer	0.000151	0.000649	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling by GPCR—SST—pancreatic cancer	0.00015	0.000647	CbGpPWpGaD
Hydrocodone—OPRM1—Class A/1 (Rhodopsin-like receptors)—CXCL8—pancreatic cancer	0.00015	0.000645	CbGpPWpGaD
Hydrocodone—OPRM1—GPCR downstream signaling—GCG—pancreatic cancer	0.000148	0.000635	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—JAG2—pancreatic cancer	0.000147	0.000633	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—HEY1—pancreatic cancer	0.000145	0.000626	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—SCT—pancreatic cancer	0.000145	0.000626	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—MEN1—pancreatic cancer	0.000145	0.000624	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—GLI1—pancreatic cancer	0.000142	0.00061	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—DTX4—pancreatic cancer	0.000142	0.00061	CbGpPWpGaD
Hydrocodone—OPRM1—GPCR downstream signaling—AGTR1—pancreatic cancer	0.000141	0.000606	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling by GPCR—CNR1—pancreatic cancer	0.000139	0.000597	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—CCK—pancreatic cancer	0.000139	0.000597	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—SHH—pancreatic cancer	0.000138	0.000595	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—NRP1—pancreatic cancer	0.000138	0.000593	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—PPP2R5B—pancreatic cancer	0.000138	0.000593	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—NOTCH4—pancreatic cancer	0.000137	0.000591	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—IAPP—pancreatic cancer	0.000137	0.000588	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—CNR2—pancreatic cancer	0.000135	0.000582	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—GLP1R—pancreatic cancer	0.000135	0.000582	CbGpPWpGaD
Hydrocodone—OPRK1—GPCR ligand binding—CXCL8—pancreatic cancer	0.000135	0.000581	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling by GPCR—GCG—pancreatic cancer	0.000134	0.000577	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—CCKAR—pancreatic cancer	0.000133	0.000572	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—HEY2—pancreatic cancer	0.000133	0.000571	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—PTHLH—pancreatic cancer	0.000131	0.000564	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—PTCH1—pancreatic cancer	0.000131	0.000564	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—GAST—pancreatic cancer	0.00013	0.000558	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—JAG2—pancreatic cancer	0.000129	0.000555	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling by GPCR—AGTR1—pancreatic cancer	0.000128	0.00055	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—MEN1—pancreatic cancer	0.000127	0.000547	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—SCT—pancreatic cancer	0.000123	0.000529	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—HEY1—pancreatic cancer	0.000123	0.000529	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—SHH—pancreatic cancer	0.000121	0.000522	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—NOTCH4—pancreatic cancer	0.000121	0.000518	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—SST—pancreatic cancer	0.00012	0.000516	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—IAPP—pancreatic cancer	0.00012	0.000515	CbGpPWpGaD
Hydrocodone—OPRD1—GPCR downstream signaling—PIK3CG—pancreatic cancer	0.000118	0.000509	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—JAG1—pancreatic cancer	0.000117	0.000505	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—CCK—pancreatic cancer	0.000117	0.000504	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—NOTCH3—pancreatic cancer	0.000117	0.000503	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—PTHLH—pancreatic cancer	0.000115	0.000495	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—PTCH1—pancreatic cancer	0.000115	0.000495	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—CNR2—pancreatic cancer	0.000114	0.000492	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—GLP1R—pancreatic cancer	0.000114	0.000492	CbGpPWpGaD
Hydrocodone—OPRM1—GPCR ligand binding—CXCL8—pancreatic cancer	0.000114	0.000491	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—CCKAR—pancreatic cancer	0.000112	0.000484	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—CNR1—pancreatic cancer	0.000111	0.000476	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—JAG2—pancreatic cancer	0.000109	0.000469	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—MEN1—pancreatic cancer	0.000107	0.000462	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling by GPCR—PIK3CG—pancreatic cancer	0.000107	0.000462	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—GCG—pancreatic cancer	0.000107	0.00046	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—SST—pancreatic cancer	0.000105	0.000452	CbGpPWpGaD
Hydrocodone—OPRD1—GPCR downstream signaling—PIK3CD—pancreatic cancer	0.000104	0.000447	CbGpPWpGaD
Hydrocodone—OPRK1—GPCR downstream signaling—PIK3CG—pancreatic cancer	0.000104	0.000446	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—JAG1—pancreatic cancer	0.000103	0.000443	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—SHH—pancreatic cancer	0.000102	0.000441	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—NOTCH3—pancreatic cancer	0.000102	0.000441	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—AGTR1—pancreatic cancer	0.000102	0.000439	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—NOTCH4—pancreatic cancer	0.000102	0.000438	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—IAPP—pancreatic cancer	0.000101	0.000435	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—STK11—pancreatic cancer	0.0001	0.000432	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—PRSS1—pancreatic cancer	9.89e-05	0.000425	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—PTHLH—pancreatic cancer	9.72e-05	0.000418	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—PTCH1—pancreatic cancer	9.72e-05	0.000418	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—CNR1—pancreatic cancer	9.7e-05	0.000417	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling by GPCR—PIK3CD—pancreatic cancer	9.44e-05	0.000406	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling by GPCR—PIK3CG—pancreatic cancer	9.42e-05	0.000405	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—GCG—pancreatic cancer	9.37e-05	0.000403	CbGpPWpGaD
Hydrocodone—OPRK1—GPCR downstream signaling—PIK3CD—pancreatic cancer	9.12e-05	0.000392	CbGpPWpGaD
Hydrocodone—OPRD1—GPCR downstream signaling—PIK3CB—pancreatic cancer	9.06e-05	0.00039	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—AGTR1—pancreatic cancer	8.94e-05	0.000385	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—SST—pancreatic cancer	8.89e-05	0.000382	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—STK11—pancreatic cancer	8.81e-05	0.000379	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—SMAD4—pancreatic cancer	8.8e-05	0.000379	CbGpPWpGaD
Hydrocodone—OPRM1—GPCR downstream signaling—PIK3CG—pancreatic cancer	8.77e-05	0.000377	CbGpPWpGaD
Hydrocodone—OPRD1—GPCR downstream signaling—CXCL8—pancreatic cancer	8.71e-05	0.000375	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—JAG1—pancreatic cancer	8.7e-05	0.000374	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—NOTCH3—pancreatic cancer	8.66e-05	0.000373	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—HES1—pancreatic cancer	8.59e-05	0.00037	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—ARG2—pancreatic cancer	8.58e-05	0.000369	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling by GPCR—PIK3CD—pancreatic cancer	8.28e-05	0.000356	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling by GPCR—PIK3CB—pancreatic cancer	8.23e-05	0.000354	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—CNR1—pancreatic cancer	8.2e-05	0.000353	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling by GPCR—PIK3CG—pancreatic cancer	7.96e-05	0.000342	CbGpPWpGaD
Hydrocodone—OPRK1—GPCR downstream signaling—PIK3CB—pancreatic cancer	7.95e-05	0.000342	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—GCG—pancreatic cancer	7.92e-05	0.000341	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling by GPCR—CXCL8—pancreatic cancer	7.91e-05	0.00034	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—SMAD4—pancreatic cancer	7.72e-05	0.000332	CbGpPWpGaD
Hydrocodone—OPRM1—GPCR downstream signaling—PIK3CD—pancreatic cancer	7.71e-05	0.000331	CbGpPWpGaD
Hydrocodone—OPRK1—GPCR downstream signaling—CXCL8—pancreatic cancer	7.64e-05	0.000328	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—AGTR1—pancreatic cancer	7.56e-05	0.000325	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—HES1—pancreatic cancer	7.54e-05	0.000324	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—TERT—pancreatic cancer	7.53e-05	0.000324	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—TYMP—pancreatic cancer	7.5e-05	0.000322	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—STK11—pancreatic cancer	7.45e-05	0.00032	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling by GPCR—PIK3CB—pancreatic cancer	7.22e-05	0.00031	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—HIF1A—pancreatic cancer	7.2e-05	0.00031	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—TSC2—pancreatic cancer	7.18e-05	0.000309	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—APOE—pancreatic cancer	7.03e-05	0.000302	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling by GPCR—PIK3CD—pancreatic cancer	7e-05	0.000301	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling by GPCR—CXCL8—pancreatic cancer	6.93e-05	0.000298	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—KDR—pancreatic cancer	6.89e-05	0.000296	CbGpPWpGaD
Hydrocodone—OPRM1—GPCR downstream signaling—PIK3CB—pancreatic cancer	6.72e-05	0.000289	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—TERT—pancreatic cancer	6.6e-05	0.000284	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—NFKBIA—pancreatic cancer	6.55e-05	0.000282	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—SMAD4—pancreatic cancer	6.52e-05	0.000281	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—NOTCH1—pancreatic cancer	6.49e-05	0.000279	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—PRSS1—pancreatic cancer	6.47e-05	0.000278	CbGpPWpGaD
Hydrocodone—OPRM1—GPCR downstream signaling—CXCL8—pancreatic cancer	6.45e-05	0.000278	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—HES1—pancreatic cancer	6.37e-05	0.000274	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—PIK3CG—pancreatic cancer	6.34e-05	0.000273	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling by GPCR—NRAS—pancreatic cancer	6.34e-05	0.000273	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—HIF1A—pancreatic cancer	6.31e-05	0.000272	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—TSC2—pancreatic cancer	6.3e-05	0.000271	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—EGF—pancreatic cancer	6.27e-05	0.00027	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—APOE—pancreatic cancer	6.16e-05	0.000265	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling by GPCR—PIK3CB—pancreatic cancer	6.1e-05	0.000262	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—GLP1R—pancreatic cancer	6.04e-05	0.00026	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—KDR—pancreatic cancer	6.04e-05	0.00026	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—DPYD—pancreatic cancer	5.94e-05	0.000256	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling by GPCR—CXCL8—pancreatic cancer	5.86e-05	0.000252	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling by GPCR—EGFR—pancreatic cancer	5.78e-05	0.000249	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—NFKBIA—pancreatic cancer	5.74e-05	0.000247	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—NOTCH1—pancreatic cancer	5.69e-05	0.000245	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—SLC2A2—pancreatic cancer	5.64e-05	0.000243	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—ARG2—pancreatic cancer	5.61e-05	0.000241	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—TERT—pancreatic cancer	5.58e-05	0.00024	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—PIK3CD—pancreatic cancer	5.58e-05	0.00024	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—PIK3CG—pancreatic cancer	5.56e-05	0.000239	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling by GPCR—NRAS—pancreatic cancer	5.56e-05	0.000239	CbGpPWpGaD
Hydrocodone—OPRD1—GPCR downstream signaling—PIK3CA—pancreatic cancer	5.52e-05	0.000238	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—EGF—pancreatic cancer	5.5e-05	0.000237	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling by GPCR—KRAS—pancreatic cancer	5.46e-05	0.000235	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—HIF1A—pancreatic cancer	5.34e-05	0.00023	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—TSC2—pancreatic cancer	5.32e-05	0.000229	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—APOE—pancreatic cancer	5.21e-05	0.000224	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—KDR—pancreatic cancer	5.1e-05	0.00022	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling by GPCR—EGFR—pancreatic cancer	5.07e-05	0.000218	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling by GPCR—PIK3CA—pancreatic cancer	5.02e-05	0.000216	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—TYMP—pancreatic cancer	4.9e-05	0.000211	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—PIK3CD—pancreatic cancer	4.89e-05	0.00021	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—PIK3CB—pancreatic cancer	4.86e-05	0.000209	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—NFKBIA—pancreatic cancer	4.85e-05	0.000209	CbGpPWpGaD
Hydrocodone—OPRK1—GPCR downstream signaling—PIK3CA—pancreatic cancer	4.84e-05	0.000208	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—NOTCH1—pancreatic cancer	4.81e-05	0.000207	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling by GPCR—KRAS—pancreatic cancer	4.79e-05	0.000206	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—PIK3CG—pancreatic cancer	4.7e-05	0.000202	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling by GPCR—NRAS—pancreatic cancer	4.7e-05	0.000202	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—CXCL8—pancreatic cancer	4.67e-05	0.000201	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—EGF—pancreatic cancer	4.65e-05	0.0002	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling by GPCR—HRAS—pancreatic cancer	4.64e-05	0.0002	CbGpPWpGaD
Hydrocodone—OPRD1—GPCR downstream signaling—AKT1—pancreatic cancer	4.51e-05	0.000194	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—CASP3—pancreatic cancer	4.47e-05	0.000192	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling by GPCR—PIK3CA—pancreatic cancer	4.4e-05	0.000189	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—CD44—pancreatic cancer	4.37e-05	0.000188	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—CCND1—pancreatic cancer	4.35e-05	0.000187	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—CTNNB1—pancreatic cancer	4.31e-05	0.000185	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling by GPCR—EGFR—pancreatic cancer	4.28e-05	0.000184	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—PIK3CB—pancreatic cancer	4.26e-05	0.000183	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—MMP9—pancreatic cancer	4.23e-05	0.000182	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—PTEN—pancreatic cancer	4.2e-05	0.000181	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—GCG—pancreatic cancer	4.19e-05	0.00018	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—PIK3CD—pancreatic cancer	4.13e-05	0.000178	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling by GPCR—AKT1—pancreatic cancer	4.1e-05	0.000176	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—CXCL8—pancreatic cancer	4.1e-05	0.000176	CbGpPWpGaD
Hydrocodone—OPRM1—GPCR downstream signaling—PIK3CA—pancreatic cancer	4.09e-05	0.000176	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling by GPCR—HRAS—pancreatic cancer	4.07e-05	0.000175	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling by GPCR—KRAS—pancreatic cancer	4.05e-05	0.000174	CbGpPWpGaD
Hydrocodone—OPRK1—GPCR downstream signaling—AKT1—pancreatic cancer	3.96e-05	0.00017	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—GLP1R—pancreatic cancer	3.95e-05	0.00017	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—STK11—pancreatic cancer	3.94e-05	0.000169	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—CASP3—pancreatic cancer	3.92e-05	0.000169	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—SRC—pancreatic cancer	3.9e-05	0.000168	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—DPYD—pancreatic cancer	3.89e-05	0.000167	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—CCND1—pancreatic cancer	3.82e-05	0.000164	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—VEGFA—pancreatic cancer	3.79e-05	0.000163	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—CTNNB1—pancreatic cancer	3.78e-05	0.000163	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—STAT3—pancreatic cancer	3.76e-05	0.000162	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—NRAS—pancreatic cancer	3.75e-05	0.000161	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling by GPCR—PIK3CA—pancreatic cancer	3.72e-05	0.00016	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—MMP9—pancreatic cancer	3.71e-05	0.000159	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—SLC2A2—pancreatic cancer	3.69e-05	0.000159	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—PTEN—pancreatic cancer	3.68e-05	0.000158	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—PIK3CB—pancreatic cancer	3.6e-05	0.000155	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling by GPCR—AKT1—pancreatic cancer	3.59e-05	0.000155	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—MYC—pancreatic cancer	3.49e-05	0.00015	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—TGFB1—pancreatic cancer	3.48e-05	0.00015	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—CXCL8—pancreatic cancer	3.46e-05	0.000149	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling by GPCR—HRAS—pancreatic cancer	3.44e-05	0.000148	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—SRC—pancreatic cancer	3.42e-05	0.000147	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—EGFR—pancreatic cancer	3.41e-05	0.000147	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—TYMS—pancreatic cancer	3.39e-05	0.000146	CbGpPWpGaD
Hydrocodone—OPRM1—GPCR downstream signaling—AKT1—pancreatic cancer	3.34e-05	0.000144	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—VEGFA—pancreatic cancer	3.33e-05	0.000143	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—CASP3—pancreatic cancer	3.31e-05	0.000143	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—STAT3—pancreatic cancer	3.29e-05	0.000142	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—NRAS—pancreatic cancer	3.29e-05	0.000141	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—KRAS—pancreatic cancer	3.23e-05	0.000139	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—CCND1—pancreatic cancer	3.23e-05	0.000139	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—CTNNB1—pancreatic cancer	3.19e-05	0.000137	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—MMP9—pancreatic cancer	3.13e-05	0.000135	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—PTEN—pancreatic cancer	3.11e-05	0.000134	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—MYC—pancreatic cancer	3.06e-05	0.000132	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—TGFB1—pancreatic cancer	3.05e-05	0.000131	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling by GPCR—AKT1—pancreatic cancer	3.04e-05	0.000131	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—EGFR—pancreatic cancer	2.99e-05	0.000129	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—PIK3CA—pancreatic cancer	2.96e-05	0.000127	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—SRC—pancreatic cancer	2.89e-05	0.000124	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—TP53—pancreatic cancer	2.87e-05	0.000123	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—CD44—pancreatic cancer	2.86e-05	0.000123	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—KRAS—pancreatic cancer	2.83e-05	0.000122	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—VEGFA—pancreatic cancer	2.81e-05	0.000121	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—STAT3—pancreatic cancer	2.78e-05	0.00012	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—NRAS—pancreatic cancer	2.78e-05	0.000119	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—APOE—pancreatic cancer	2.75e-05	0.000118	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—HRAS—pancreatic cancer	2.74e-05	0.000118	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—GCG—pancreatic cancer	2.74e-05	0.000118	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—PIK3CA—pancreatic cancer	2.6e-05	0.000112	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—MYC—pancreatic cancer	2.59e-05	0.000111	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—TGFB1—pancreatic cancer	2.58e-05	0.000111	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—STK11—pancreatic cancer	2.57e-05	0.000111	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—EGFR—pancreatic cancer	2.53e-05	0.000109	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—TP53—pancreatic cancer	2.51e-05	0.000108	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—PIK3CG—pancreatic cancer	2.49e-05	0.000107	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—AKT1—pancreatic cancer	2.42e-05	0.000104	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—HRAS—pancreatic cancer	2.4e-05	0.000103	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—PPARG—pancreatic cancer	2.4e-05	0.000103	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—KRAS—pancreatic cancer	2.39e-05	0.000103	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—TYMS—pancreatic cancer	2.21e-05	9.52e-05	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—PIK3CA—pancreatic cancer	2.2e-05	9.45e-05	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—PIK3CD—pancreatic cancer	2.19e-05	9.4e-05	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—TP53—pancreatic cancer	2.12e-05	9.14e-05	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—AKT1—pancreatic cancer	2.12e-05	9.13e-05	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—HRAS—pancreatic cancer	2.03e-05	8.74e-05	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—PIK3CB—pancreatic cancer	1.9e-05	8.19e-05	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—PTGS2—pancreatic cancer	1.89e-05	8.12e-05	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—APOE—pancreatic cancer	1.8e-05	7.75e-05	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—AKT1—pancreatic cancer	1.79e-05	7.72e-05	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—PTEN—pancreatic cancer	1.65e-05	7.08e-05	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—PIK3CG—pancreatic cancer	1.63e-05	6.99e-05	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—PPARG—pancreatic cancer	1.57e-05	6.75e-05	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—PIK3CD—pancreatic cancer	1.43e-05	6.15e-05	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—PIK3CB—pancreatic cancer	1.25e-05	5.36e-05	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—PTGS2—pancreatic cancer	1.23e-05	5.31e-05	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—PIK3CA—pancreatic cancer	1.16e-05	4.99e-05	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—PTEN—pancreatic cancer	1.08e-05	4.63e-05	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—AKT1—pancreatic cancer	9.49e-06	4.08e-05	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—PIK3CA—pancreatic cancer	7.59e-06	3.27e-05	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—AKT1—pancreatic cancer	6.2e-06	2.67e-05	CbGpPWpGaD
